Semitala Fred C, Katwesigye Rodgers, Kalibbala Dennis, Mbuliro Mary, Rejani Lalitha, Owachi Darius, Atine Edgar, Turyahabwe Stavia, Sekadde Moorine P
Department of Internal Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Makerere University Joint AIDS Program (MJAP), Kampala, Uganda.
BMC Infect Dis. 2024 Jul 31;24(1):762. doi: 10.1186/s12879-024-09667-5.
Following the World Health Organization's declaration of COVID-19 as a global pandemic, several countries implemented population-wide lockdowns. However, these responses to COVID-19 caused severe healthcare system disruptions to service delivery. The TB case notification rate in Uganda decreased by 22% between January and April 2020, which coincided with a lockdown and an increase in COVID-19 cases. In this study, we tested the effect of screening all patients with both COVID-19-positive and negative symptom screen for TB at a National Referral Hospital.
DESIGN/METHODS: Following our formative assessment, we identified potential barriers to and facilitators of integrating screening for COVID-19 and TB at Kiruddu National Referral Hospital. To address the barriers, in February 2021 we trained healthcare providers on integrated COVID-19-TB screening tools and provided COVID-19/TB screening tools/Standard operating procedures and personal protective equipment. From March 1, 2021, to June 30, 2021, we screened patients presenting to the emergency and outpatient departments for COVID-19 symptoms, and subsequently, we performed TB symptom screening for both patients with COVID-19 positive and negative symptom screen using the intensified tuberculosis case-finding (ICF) guide. We then compared the outcomes of TB symptom screening for patients initially with a positive COVID-19 symptom screen with those who initially had a negative COVID-19 symptom screen.
From March 2021 to June 2021, we screened 1464 patients (44.3% male and 55.7% female) for COVID-19 symptoms. Out of these participants, 1252 (85.5%) screened positive for COVID-19 symptoms, while 212 (14.5%) screened negative. The majority of patients with a positive COVID-19 symptom screen, 717 (57.3%), also screened positive for TB symptoms compared to 19 (8.9%) among patients with a negative COVID-19 symptom screen. Out of the total 736 presumptive TB cases identified, 717 (97.4%) initially screened positive for COVID-19 symptoms. TB was diagnosed in 110 individuals including 104 who had positive COVID-19-symptom screen and six who had a negative COVID-19 symptom screen. All of the 110 newly diagnosed TB cases were linked to TB treatment.
Patients who screen positive for COVID-19 symptoms should be routinely screened for TB to mitigate missed opportunities for TB case identification.
在世界卫生组织宣布新冠疫情为全球大流行之后,多个国家实施了全面封锁措施。然而,这些针对新冠疫情的应对措施严重扰乱了医疗系统的服务提供。乌干达的结核病病例报告率在2020年1月至4月间下降了22%,这一时期恰逢封锁以及新冠病例增加。在本研究中,我们在一家国家转诊医院测试了对所有新冠症状筛查呈阳性和阴性的患者进行结核病筛查的效果。
设计/方法:在进行形成性评估之后,我们确定了在基鲁杜国家转诊医院整合新冠和结核病筛查的潜在障碍与促进因素。为克服这些障碍,2021年2月我们对医护人员进行了新冠-结核病综合筛查工具的培训,并提供了新冠/结核病筛查工具/标准操作程序以及个人防护装备。从2021年3月1日至2021年6月30日,我们对前往急诊科和门诊部就诊的患者进行新冠症状筛查,随后,我们使用强化结核病病例发现(ICF)指南对新冠症状筛查呈阳性和阴性的患者都进行了结核病症状筛查。然后我们比较了最初新冠症状筛查呈阳性的患者与最初新冠症状筛查呈阴性的患者的结核病症状筛查结果。
2021年3月至2021年6月,我们对1464名患者(44.3%为男性,55.7%为女性)进行了新冠症状筛查。在这些参与者中,1252人(85.5%)新冠症状筛查呈阳性,而212人(14.5%)筛查呈阴性。新冠症状筛查呈阳性的患者中,大多数717人(57.3%)结核病症状筛查也呈阳性,而新冠症状筛查呈阴性的患者中这一比例为19人(8.9%)。在总共确定的736例疑似结核病病例中,717例(97.4%)最初新冠症状筛查呈阳性。110人被诊断为结核病,其中104人新冠症状筛查呈阳性,6人新冠症状筛查呈阴性。所有110例新诊断的结核病病例均与结核病治疗相关。
新冠症状筛查呈阳性的患者应常规进行结核病筛查,以减少结核病病例识别的漏诊机会。